Patent ID: 9326967
Filing Date: 2016-05-03
CPC Classification: A61K,A61L,A61M

Claim Text:
1. A vaporizable composition that is inhalable after vaporization comprising: a cannabinoid capable of inducing a pharmacological effect, wherein the cannabinoid comprises an endocannabinoid, a phytocannabinoid, or a synthetic cannabinoid; selected from at least one of the group consisting of: a fatty acid ester (FAE), cetyl palmitate, colfosceril palmitate, ethylhexyl palmitate, isopropyl palmitate, palmitic acid, palmitoyl-CoA, retinyl palmitate, and sucrose monopalmitate; a condensation aerosol comprising a mass median aerodynamic diameter (MMAD) of about 0.1 microns to about 5 microns; and a glycol-free carrier liquid solution comprised of food grade materials; wherein the composition is absorbable by a mucosa via inhalation after the composition is vaporized by heating; wherein the cannabinoid is a bio-active ingredient receivable by a cannabinoid receptor or an acetylcholine receptor; wherein the pharmacological effect is produced by reception by the cannabinoid receptor or the acetylcholine receptor of tetrahydrocannabinol, cannabidiol, or a mixture of the tetrahydrocannabinol and the cannabidiol; wherein the cannabinoid comprises at least one ingredient selected from the group consisting of: tetrahydrocannabinol, cannabidiol, cannabinol, dodeca-2E,4E,8Z,10E/Z-tetraenoic-acid-isobutylamides, cannabigerol, cannabichromene, cannabicyclol, cannabivarin, tetrahydrocannabivarin, cannabidivarin, cannabichromevarin, cannabigerovarin, cannabigerol monomethyl ether, an aminoalkylindole, a 1,5-diarylpyrazole, a quinoline, an arylsulphonamide, an eicosanoid, and a mixture of two of more of the foregoing.